Avitas Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$5.53M Buy
55,585
+7,863
+16% +$811K 0.76% 31
2024
Q3
$5.42M Buy
47,722
+634
+1% +$75.3K 0.76% 32
2024
Q2
$5.83M Buy
47,088
+140
+0.3% +$18K 0.85% 27
2024
Q1
$6.19M Buy
46,948
+556
+1% +$68.5K 0.94% 26
2023
Q4
$5.06M Buy
46,392
+1,477
+3% +$153K 0.85% 32
2023
Q3
$4.62M Sell
44,915
-227
-0.5% -$24.5K 0.88% 29
2023
Q2
$5.21M Buy
45,142
+271
+0.6% +$30.8K 0.94% 25
2023
Q1
$4.77M Sell
44,871
-505
-1% -$54.5K 0.93% 27
2022
Q4
$5.03M Sell
45,376
-724
-2% -$74K 1.06% 25
2022
Q3
$3.97M Buy
46,100
+711
+2% +$63.5K 0.91% 28
2022
Q2
$4.14M Buy
45,389
+634
+1% +$56.2K 0.91% 31
2022
Q1
$3.67M Sell
44,755
-16,751
-27% -$1.32M 0.66% 43
2021
Q4
$4.71M Buy
61,506
+1,115
+2% +$88.8K 0.79% 46
2021
Q3
$4.54M Buy
60,391
+31
+0.1% +$2.36K 0.83% 45
2021
Q2
$4.69M Sell
60,360
-1,082
-2% -$80.5K 0.84% 36
2021
Q1
$4.52M Buy
61,442
+19,295
+46% +$1.42M 0.89% 34
2020
Q4
$3.29M Buy
42,147
+845
+2% +$64.6K 0.67% 46
2020
Q3
$3.27M Buy
41,302
+402
+1% +$31.5K 0.91% 32
2020
Q2
$3.02M Sell
40,900
-1,492
-4% -$112K 1% 26
2020
Q1
$3.11M Sell
42,392
-10,238
-19% -$805K 1.42% 23
2019
Q4
$4.57M Buy
52,630
+125
+0.2% +$10.3K 1.17% 18
2019
Q3
$4.22M Buy
52,505
+874
+2% +$70K 1.16% 20
2019
Q2
$4.13M Sell
51,631
-7,610
-13% -$583K 1.15% 20
2019
Q1
$4.7M Buy
59,241
+665
+1% +$49.7K 1.37% 16
2018
Q4
$4.27M Buy
58,576
+1,039
+2% +$73.3K 1.4% 14
2018
Q3
$3.9M Buy
57,537
+2,216
+4% +$141K 1.11% 25
2018
Q2
$3.2M Buy
+55,321
New +$3.12M 1% 31

Other funds holding MRK

Avitas Wealth Management's MRK Position: Q4 2024 in Review

Avitas Wealth Management increased its Merck (MRK) stake by 16% in Q4 2024, buying an estimated $811K and bringing the position to 55,585 shares worth $5.53M. The position accounts for 0.76% of the portfolio, ranked #31.

Avitas Wealth Management first reported a position in MRK in Q2 2018 and has held it in 27 quarters since. The position peaked at $6.19M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Avitas Wealth Management held 55,585 shares of Merck worth $5.53M as of Q4 2024.
  • Avitas Wealth Management bought 7,863 Merck shares in Q4 2024, an estimated $811K.
  • Merck made up 0.76% of Avitas Wealth Management's portfolio in Q4 2024, its #31 holding.
  • Avitas Wealth Management first reported a position in Merck in Q2 2018 and has held it in 27 quarters since.
  • Avitas Wealth Management's Merck position peaked at $6.19M in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Avitas Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.